TissueCypher® Further Validated to Accurately Risk Stratify Barrett’s Esophagus Patients with Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences
Data presented at ACG, UEGW illustrates the 4th independent validation of TissueCypher performance for risk stratifying non-dysplastic Barrett’s esophagus (NDBE) patients; expands indication for testing low-grade dysplasia (LGD) PITTSBURGH, ...
Read more